Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.61 billion. The enterprise value is $1.75 billion.
| Market Cap | 1.61B |
| Enterprise Value | 1.75B |
Important Dates
The last earnings date was Thursday, February 19, 2026, before market open.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 81.07 million shares outstanding. The number of shares has increased by 2.33% in one year.
| Current Share Class | 81.07M |
| Shares Outstanding | 81.07M |
| Shares Change (YoY) | +2.33% |
| Shares Change (QoQ) | -1.40% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 102.45% |
| Float | 79.95M |
Valuation Ratios
The trailing PE ratio is 10.25 and the forward PE ratio is 8.90.
| PE Ratio | 10.25 |
| Forward PE | 8.90 |
| PS Ratio | 0.84 |
| Forward PS | 0.80 |
| PB Ratio | 1.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.38 |
| P/OCF Ratio | 5.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.91, with an EV/FCF ratio of 6.91.
| EV / Earnings | 10.56 |
| EV / Sales | 0.91 |
| EV / EBITDA | 6.91 |
| EV / EBIT | 7.56 |
| EV / FCF | 6.91 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.66 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 2.35 |
| Debt / FCF | 2.51 |
| Interest Coverage | 6.43 |
Financial Efficiency
Return on equity (ROE) is 20.28% and return on invested capital (ROIC) is 17.06%.
| Return on Equity (ROE) | 20.28% |
| Return on Assets (ROA) | 6.57% |
| Return on Invested Capital (ROIC) | 17.06% |
| Return on Capital Employed (ROCE) | 12.93% |
| Weighted Average Cost of Capital (WACC) | 7.38% |
| Revenue Per Employee | $447,161 |
| Profits Per Employee | $38,642 |
| Employee Count | 4,280 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $51.04 million in taxes.
| Income Tax | 51.04M |
| Effective Tax Rate | 23.58% |
Stock Price Statistics
The stock price has increased by +37.01% in the last 52 weeks. The beta is 0.79, so MD's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +37.01% |
| 50-Day Moving Average | 21.23 |
| 200-Day Moving Average | 17.89 |
| Relative Strength Index (RSI) | 42.89 |
| Average Volume (20 Days) | 968,274 |
Short Selling Information
The latest short interest is 2.96 million, so 3.66% of the outstanding shares have been sold short.
| Short Interest | 2.96M |
| Short Previous Month | 3.04M |
| Short % of Shares Out | 3.66% |
| Short % of Float | 3.71% |
| Short Ratio (days to cover) | 5.53 |
Income Statement
In the last 12 months, MD had revenue of $1.91 billion and earned $165.39 million in profits. Earnings per share was $1.94.
| Revenue | 1.91B |
| Gross Profit | 493.70M |
| Operating Income | 231.09M |
| Pretax Income | 216.43M |
| Net Income | 165.39M |
| EBITDA | 252.91M |
| EBIT | 231.09M |
| Earnings Per Share (EPS) | $1.94 |
Balance Sheet
The company has $499.72 million in cash and $634.62 million in debt, with a net cash position of -$134.89 million or -$1.66 per share.
| Cash & Cash Equivalents | 499.72M |
| Total Debt | 634.62M |
| Net Cash | -134.89M |
| Net Cash Per Share | -$1.66 |
| Equity (Book Value) | 865.85M |
| Book Value Per Share | 10.68 |
| Working Capital | 304.60M |
Cash Flow
In the last 12 months, operating cash flow was $271.09 million and capital expenditures -$18.46 million, giving a free cash flow of $252.63 million.
| Operating Cash Flow | 271.09M |
| Capital Expenditures | -18.46M |
| Free Cash Flow | 252.63M |
| FCF Per Share | $3.12 |
Margins
Gross margin is 25.80%, with operating and profit margins of 12.07% and 8.64%.
| Gross Margin | 25.80% |
| Operating Margin | 12.07% |
| Pretax Margin | 11.31% |
| Profit Margin | 8.64% |
| EBITDA Margin | 13.21% |
| EBIT Margin | 12.07% |
| FCF Margin | 13.20% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.33% |
| Shareholder Yield | -2.33% |
| Earnings Yield | 10.26% |
| FCF Yield | 15.68% |
Analyst Forecast
The average price target for MD is $20.00, which is 0.60% higher than the current price. The consensus rating is "Hold".
| Price Target | $20.00 |
| Price Target Difference | 0.60% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 4.60% |
| EPS Growth Forecast (5Y) | 2.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.89 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.89 |
| Piotroski F-Score | 7 |